Mucus-permeable polymyxin B-hyaluronic acid/ poly (lactic-co-glycolic acid) nanoparticle platform for the nebulized treatment of lung infections.
J Colloid Interface Sci
; 624: 307-319, 2022 Oct 15.
Article
in En
| MEDLINE
| ID: mdl-35660900
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Nanoparticles
/
Hyaluronic Acid
Limits:
Animals
Language:
En
Journal:
J Colloid Interface Sci
Year:
2022
Document type:
Article